Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-07-17
2007-07-17
Schnizer, Richard (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000, C530S323000
Reexamination Certificate
active
11058988
ABSTRACT:
Compositions and methods of using compositions with a nuclear targeting peptide containing a nonclassical nuclear localization signal to deliver selected molecules to the nucleus of eukaryotic cells are provided. The compositions are particularly useful in gene transfer methods.
REFERENCES:
patent: 5922859 (1999-07-01), Birnstiel et al.
patent: 6927278 (2005-08-01), Diamond
patent: WO 96 41606 (1996-12-01), None
patent: WO 96/41606 (1996-12-01), None
patent: WO 92/13570 (1999-07-01), None
Gorlich (Current Opinion in Cell Biology, (Jun. 1997) vol. 9, No. 3, pp. 412-419).
Grondin et al (J. Biol. Chem. 271(26): 15458-15467, 1996).
Sachdev et al (Mol. Cell. Biol. 18(5): 2524-2534, 1998).
Fan et al (PNAS 95: 15293-15298, 1998).
Rudinger (In Peptide Hormones J.A. Parsons, Ed. University Park Press, Baltimore, 1976, pp. 1, 6, and 7).
Ngo et al (In The Protein Folding Problem and Tertiary Structure Prediction, K. Merz Jr. and S. Legrand, Eds. Birkhauser, Boston, 1994, pp. 433 and 492-495.).
Verma et al (Nature 389: 239-242, 1997).
Anderson (Nature 392:25-30, 1998).
Romano et al (Stem Cells 18: 19-39, 2000).
Somia and Verma (Nature Reviews Genetics 1: 91-99, 2000).
Michael et al (Cell 82(3): 415-422, 1995).
Gallouzi et al (SCIENCE, (Nov. 30, 2001) 294 (5548) 1895-901).
Michael et al (EMBO J. 16(12): 3587-3598, 1997).
GenBank Accession No. I39311, (Dec. 1, 2000).
Jakel et al (EMBO Journal, (May 4, 1999) 18 (9) 2411-23).
GenBank Accession No. 1K5J E (Oct. 10, 2001).
Jans et al., “Signals Mediating Nuclear Targeting and Their Regulation: Application in Drug Delivery”,Medicinal Research Reviews1998 18:4 189-223.
Chan et al., “Mutual exclusivity of DNA binding and nuclear localization signal recognition by the yeast transcription factor GAL4:implications for nonviral DNA delivery”Gene Therapy1998 5:1204-1212.
Shen W-C., “Nuclear import of DNA:the ultimate targeting in gene therapy”,Journal of Drug Targeting1997 5(1): 11-13.
Licata & Tyrrell P.C.
Schnizer Richard
Trustees of the University of Pennsylvania
LandOfFree
Peptide scaffolds for transfer of molecules into eukaryotic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide scaffolds for transfer of molecules into eukaryotic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide scaffolds for transfer of molecules into eukaryotic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3762879